| Dr Daniel Edward Hatz, MD | |
|
2501 Capehart Rd, Offutt Afb, NE 68113-1043 | |
| (402) 740-7710 | |
| Not Available |
| Full Name | Dr Daniel Edward Hatz |
|---|---|
| Gender | Male |
| Speciality | Orthopaedic Surgery |
| Location | 2501 Capehart Rd, Offutt Afb, Nebraska |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407174584 | NPI | - | NPPES |
| Entity Name | St Marys Community Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528016995 PECOS PAC ID: 7113831926 Enrollment ID: O20031218000943 |
News Archive
Eisai Inc. announced today that the U.S. Food and Drug Administration has granted orphan drug designation to its investigational compound (E7777) for cutaneous t-cell lymphoma. E7777 is designed to have an improved purity profile and manufacturing process.
Novelos Therapeutics, Inc., a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today announced that the University of Wisconsin Carbone Cancer Center, a leading oncology research institution, has enrolled the first patient in a Phase 1-2 positron emission tomography (PET) imaging trial of I-124-CLR1404, a cancer-targeted PET imaging agent, in patients with nine solid tumor types, including triple negative breast, soft tissue sarcoma, colorectal, gastric, esophageal, prostate, ovarian, pancreatic and head & neck cancer.
The "female sex hormone" estradiol is present in both men and women, and is generated from testosterone in men by the protein aromatase.
How much time does the average person spend reviewing their health care insurance when it's time to enroll or reenroll in a plan? A recent survey conducted for CIGNA shows that although 78 percent said they give it a lot or some consideration, almost half (46%) of those who say they're responsible for the review spend less than 30 minutes on the task.
› Verified 6 days ago
| Entity Name | St Marys Community Hospital |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1528016995 PECOS PAC ID: 7113831926 Enrollment ID: O20071128000886 |
News Archive
Eisai Inc. announced today that the U.S. Food and Drug Administration has granted orphan drug designation to its investigational compound (E7777) for cutaneous t-cell lymphoma. E7777 is designed to have an improved purity profile and manufacturing process.
Novelos Therapeutics, Inc., a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today announced that the University of Wisconsin Carbone Cancer Center, a leading oncology research institution, has enrolled the first patient in a Phase 1-2 positron emission tomography (PET) imaging trial of I-124-CLR1404, a cancer-targeted PET imaging agent, in patients with nine solid tumor types, including triple negative breast, soft tissue sarcoma, colorectal, gastric, esophageal, prostate, ovarian, pancreatic and head & neck cancer.
The "female sex hormone" estradiol is present in both men and women, and is generated from testosterone in men by the protein aromatase.
How much time does the average person spend reviewing their health care insurance when it's time to enroll or reenroll in a plan? A recent survey conducted for CIGNA shows that although 78 percent said they give it a lot or some consideration, almost half (46%) of those who say they're responsible for the review spend less than 30 minutes on the task.
› Verified 6 days ago
| Entity Name | Columbus Community Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821592205 PECOS PAC ID: 7517954944 Enrollment ID: O20120508000181 |
News Archive
Eisai Inc. announced today that the U.S. Food and Drug Administration has granted orphan drug designation to its investigational compound (E7777) for cutaneous t-cell lymphoma. E7777 is designed to have an improved purity profile and manufacturing process.
Novelos Therapeutics, Inc., a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today announced that the University of Wisconsin Carbone Cancer Center, a leading oncology research institution, has enrolled the first patient in a Phase 1-2 positron emission tomography (PET) imaging trial of I-124-CLR1404, a cancer-targeted PET imaging agent, in patients with nine solid tumor types, including triple negative breast, soft tissue sarcoma, colorectal, gastric, esophageal, prostate, ovarian, pancreatic and head & neck cancer.
The "female sex hormone" estradiol is present in both men and women, and is generated from testosterone in men by the protein aromatase.
How much time does the average person spend reviewing their health care insurance when it's time to enroll or reenroll in a plan? A recent survey conducted for CIGNA shows that although 78 percent said they give it a lot or some consideration, almost half (46%) of those who say they're responsible for the review spend less than 30 minutes on the task.
› Verified 6 days ago
| Entity Name | Chi Health Clinic Specialty Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285138065 PECOS PAC ID: 4789098443 Enrollment ID: O20210121000492 |
News Archive
Eisai Inc. announced today that the U.S. Food and Drug Administration has granted orphan drug designation to its investigational compound (E7777) for cutaneous t-cell lymphoma. E7777 is designed to have an improved purity profile and manufacturing process.
Novelos Therapeutics, Inc., a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today announced that the University of Wisconsin Carbone Cancer Center, a leading oncology research institution, has enrolled the first patient in a Phase 1-2 positron emission tomography (PET) imaging trial of I-124-CLR1404, a cancer-targeted PET imaging agent, in patients with nine solid tumor types, including triple negative breast, soft tissue sarcoma, colorectal, gastric, esophageal, prostate, ovarian, pancreatic and head & neck cancer.
The "female sex hormone" estradiol is present in both men and women, and is generated from testosterone in men by the protein aromatase.
How much time does the average person spend reviewing their health care insurance when it's time to enroll or reenroll in a plan? A recent survey conducted for CIGNA shows that although 78 percent said they give it a lot or some consideration, almost half (46%) of those who say they're responsible for the review spend less than 30 minutes on the task.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Daniel Edward Hatz, MD 2501 Capehart Rd, Bellevue, NE 68123-0000 Ph: (402) 740-7710 | Dr Daniel Edward Hatz, MD 2501 Capehart Rd, Offutt Afb, NE 68113-1043 Ph: (402) 740-7710 |
News Archive
Eisai Inc. announced today that the U.S. Food and Drug Administration has granted orphan drug designation to its investigational compound (E7777) for cutaneous t-cell lymphoma. E7777 is designed to have an improved purity profile and manufacturing process.
Novelos Therapeutics, Inc., a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today announced that the University of Wisconsin Carbone Cancer Center, a leading oncology research institution, has enrolled the first patient in a Phase 1-2 positron emission tomography (PET) imaging trial of I-124-CLR1404, a cancer-targeted PET imaging agent, in patients with nine solid tumor types, including triple negative breast, soft tissue sarcoma, colorectal, gastric, esophageal, prostate, ovarian, pancreatic and head & neck cancer.
The "female sex hormone" estradiol is present in both men and women, and is generated from testosterone in men by the protein aromatase.
How much time does the average person spend reviewing their health care insurance when it's time to enroll or reenroll in a plan? A recent survey conducted for CIGNA shows that although 78 percent said they give it a lot or some consideration, almost half (46%) of those who say they're responsible for the review spend less than 30 minutes on the task.
› Verified 6 days ago
Dr. Andrew Jason Myrtue, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2501 Capehart Rd, Offutt Afb, NE 68113 Phone: 402-294-6606 |